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Abstract
AIM
To evaluate the potential effectiveness of robot-assisted 
gastrectomy (RAG) in comparison to open gastrectomy 
(OG) for gastric cancer patients. 
METHODS
A comprehensive systematic literature search using 
PubMed, EMBASE, and the Cochrane Library was carried 
out to identify studies comparing RAG and OG in gastric 
cancer. Participants of any age and sex were considered 
for inclusion in comparative studies of the two techniques 
independently from type of gastrectomy. A meta-analysis 
of short-term perioperative outcomes was performed to 
evaluate whether RAG is equivalent to OG. The primary 
outcome measures were set for estimated blood loss, 
operative time, conversion rate, morbidity, and hospital 
stay. Secondary among postoperative complications, 
wound infection, bleeding and anastomotic leakage were 
also analysed.
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RESULTS
A total of 6 articles, 5 retrospective and 1 randomized 
controlled study, involving 6123 patients overall, with 
689 (11.3%) cases submitted to RAG and 5434 (88.7%) 
to OG, satisfied the eligibility criteria and were included 
in the meta-analysis. RAG was associated with longer 
operation time than OG (weighted mean difference 72.20 
min; P  < 0.001), but with reduction in blood loss and 
shorter hospital stay (weighted mean difference -166.83 
mL and -1.97 d respectively; P  < 0.001). No differences 
were found with respect to overall postoperative comp-
lications (P  = 0.65), wound infection (P  = 0.35), bleeding 
(P  = 0.65), and anastomotic leakage (P  = 0.06). The 
postoperative mortality rates were similar between the 
two groups. With respect to oncological outcomes, no 
statistical differences among the number of harvested 
lymph nodes were found (weighted mean difference 
-1.12; P  = 0.10).
CONCLUSION
RAG seems to be a technically valid alternative to OG for 
performing radical gastrectomy in gastric cancer resulting 
in safe complications. 
Key words: Robot-assisted gastrectomy; Gastric resection; 
Open gastrectomy; Gastric cancer
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Core tip: We took into consideration how safe and efficient 
robot-assisted gastrectomy (RAG) is compared to open 
gastrectomy (OG) for gastric cancer via  systematic review 
and meta-analysis. The available studies to date and the 
analysis of pooled data extracted from these showed 
that RAG is safe and feasible, making it possible to obtain 
lower blood loss related to surgery and a more rapid 
patient recovery. At the same time similar lymph node 
dissection between the two techniques were revealed. 
We can reasonably expect that the innovative robotic 
technique could represent a valid alternative with potential 
benefit to equal oncological adequacy with respect to OG.
Caruso S, Patriti A, Roviello F, De Franco L, Franceschini F, 
Ceccarelli G, Coratti A. Robot-assisted laparoscopic vs open 
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from: URL: http://www.wjgnet.com/2218-4333/full/v8/i3/273.
htm  DOI: http://dx.doi.org/10.5306/wjco.v8.i3.273
INTRODUCTION
Since its introduction by Kitano et al[1] in 1994, laparoscopy 
has been increasingly used for the treatment of gastric 
cancer. During this period of time, a number of works have 
shown laparoscopic gastrectomy (LG) to be a feasible 
option in treating gastric cancer and level Ⅲ studies 
provided the evidence that laparoscopic assisted distal 
gastrectomy (LADG) leads to better results in the short-
term than conventionally performed open gastrectomy 
(OG) for early gastric cancer[2-5]. Due to the high incidence 
of gastric cancer and the extremely high levels of 
expertise achieved by Asian surgeons, LG is now a routine 
procedure for early gastric cancer in eastern states[6]. On 
the other hand, laparoscopic surgery did not meet the 
same widespread requirements for the management 
of advanced gastric cancer, mainly due to the technical 
difficulties posed by the D2 lymphadenectomy and 
the intestinal reconstruction after total gastrectomy. 
Concerns regarding oncological adequacy, in particular 
for potential inadequate lymphadenectomy and long-
term outcomes[6,7], make LG for advanced gastric cancer 
still questionable. Therefore, a significant proportion of 
patients with advanced stage disease are still treated 
with OG, especially in Western countries. In an effort to 
overcome the technical disadvantages of laparoscopic 
technique, robotic surgery has been introduced and it has 
gradually spread worldwide. Robotic systems have three-
dimensional (3D) high-resolution imaging, tremor filter, and 
internal articulated endoscopic wrist (EndoWrist™ System), 
which lead to significant improvements in visibility and 
manipulation with respect to conventional laparoscopy. 
With this advanced equipment, robot-assisted gastrectomy 
(RAG) has been advocated to give a global advantage 
over the traditional laparoscopic approach, particularly 
in performing the D2 lymphadenectomy and facilitating 
complex reconstruction after gastrectomy[8-10]. A variety of 
reports have demonstrated the safety and feasibility of this 
technique[6]. However, so far most of the reports derives 
from not large, retrospective, non-randomized studies. 
In order to achieve a confirmed acceptance, an 
innovative technique with minimum invasiveness absolutely 
has to show that it is not disadvantageous to oncologic 
result. As LG still has not reached a comprehensive 
validation for the treatment of all (advanced) gastric cancer, 
the introduction of robotic surgery can represent a fair cue 
of advancement potentially able to make the laparoscopic 
technique more oncologically adequate, and so to increase 
its use as alternative procedure to the conventional open 
approach. Yet, to date a mere handful of trials have shown 
high quality comparative analysis of RAG vs OG in the 
treatment of gastric cancer, and most of these studies have 
been limited to small sample size and a single institution 
design. To overcome these limitations, we performed a 
systematic review and meta-analysis which can increase 
the statistical power of short-term results available so far 
on these two techniques. Thus, relevant trials comparing 
the safety and efficacy of RAG vs OG in treating gastric 
cancer were analyzed, to verify if at present there is actual 
evidence of an advantage to the introduction of this new 
minimally invasive technique with respect to the validated 
open procedure. Positive results could represent the 
preliminary impulse to potentiate the robotic tool which, 
by overcoming some intrinsic limits of the conventional 
laparoscopic method, might increase the use and 
acceptance of the minimally invasive procedure for gastric 
cancer in the future. 
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MATERIALS AND METHODS
Literature search
A comprehensive systematic literature search was 
conducted using PubMed, EMBASE, and the Cochrane 
Library to identify relevant articles comparing RAG vs 
OG for the treatment of gastric cancer published up 
to December 2016. The Preferred Reporting Items 
for Systematic Reviews and Meta-Analysis (PRISMA) 
statement guidelines were adopted for performing and 
reporting meta-analysis data[11]. No restriction was set 
for type and date of publication, and for age and sex 
of participants. Article language was limited to English. 
The following terms were used for the search strategy: 
“Robot” or “robotic” or “robot-assisted” or “robotic-
assisted” and “open” in combination with “gastrectomy” 
or “gastric resection” or “gastric cancer” or “stomach 
cancer” or “gastric carcinoma”. Either free-text and 
medical subject heading (MeSH) searches were used 
for keywords. The search was further broadened by 
extensive cross-checking of all reference in the retrieved 
articles fulfilling the inclusion criteria in order to identify 
eventual additional non indexed literature. Discrepancies 
in the search were resolved by consensus discussion 
among the entire author group. All relevant texts, tables 
and figures were reviewed for data extraction. 
Study selection
Two authors (FF and LDF) independently screened 
the primary data from the studies identified in the 
electronic search. The initial assessed data included 
authors, titles and abstract. Then, the following inclusion 
criteria were set for inclusion the studies in the meta-
analysis: (1) trials comparing robotic and OG for gastric 
adenocarcinoma, independently from the type of gas-
trectomy (distal gastrectomy, proximal gastrectomy and 
total gastrectomy) and tumour stage (early or advanced 
gastric cancer); and (2) Studies reporting at least one 
of the perioperative outcome measures among the 
following: Operative blood loss, operative time, numbers 
of harvested lymph nodes, postoperative complication 
rate, postoperative mortality, and hospital stay (interval 
from operation to discharge).
The following exclusion criteria were set: (1) duplicate 
studies; (2) non-comparative studies; (3) if publications 
are reviews, conference abstracts, letters, comments or 
case reports; (4) non-relevant topic papers or when all 
the reported appropriate outcomes were not included; (5) 
studies where it was not possible to extract or calculate 
data of interest from the published results; and (6) if 
more than one study was reported by the same institute, 
the most recent work or that containing more complete 
data was selected. 
Primary relevant data from the original included studies 
were independently extracted and summarized by the 
same two authors. In addition, in terms of postoperative 
complications, anastomotic leakage, bleeding, as well as 
wound infection were also analyzed when reported. Any 
disagreement was resolved by consensus among the 
author group. 
Quality assessment
The modified Newcastle-Ottawa Scale was used to 
assess the methodological quality of retrospective 
non randomized studies[12]. The scale consists of eight 
multiple-choice questions assessed essentially on three 
major categories: Patient selection, comparability (of 
cases and controls in case-control studies, of cohorts in 
cohort studies), and the assessment of the outcome (in 
case-control studies) or exposure (in cohort studies)[12]. 
The number of possible answers per question ranges 
from 2 to 5. High-quality responses earn a star, totaling 
up to nine stars (the comparability question earns up to 
two stars).
The quality of randomized clinical trials was assessed 
using Jadad’s scoring system[13]. The Jadad’s scale, 
widely validated for reporting randomized controlled 
trials quality, assess a score (ranging 0 to 6) on the base 
of three major elements: randomization (0-2 points), 
blinding (0-2 points) and patients withdrawal (0-1 point). 
Risk of bias
Assessment for potential publication bias was analysed 
through drawing of funnel plots which were inspected for 
asymmetry for all outcome measures and evaluated by 
the Begg’s[14] and Egger’s tests[15].
Statistical analysis
The statistical analysis was performed using Review 
Manager software version 5.3 (RevMan 5.3, Cochrane 
Collaboration, Oxford, United Kingdom). Weighted 
mean differences (WMD) and odds ratios (OR) were 
used as a summary measure of efficacy for continuous 
and dichotomous variables respectively. A 95%CI was 
reported.
Statistical heterogeneity among the studies was 
evaluated using the χ 2
 
test and according to the Higgins’ 
I2 statistic[16]. I2 values of 0-25%, 25%-50% and > 50% 
were considered as indicative of homogeneity, moderate 
heterogeneity and high heterogeneity, respectively[17]. 
To estimate the pooled WMD or OR, the inverse variance 
method with fixed-effects model was applied when no 
or moderate heterogeneity was detected among studies 
(I2 < 50%) according to Mantel-Haenszel method[18], 
whereas the random-effect model was used for analysis 
when I2 was greater than 50% (DerSimonian and Laird 
method)[19]. WMD was pooled by using the inverse 
variance model. The Z test was used to determine the 
pooled WMD or OR. Sensitivity analyses and funnel plots 
were assumed to investigate potential publication bias.
Funnel plot asymmetry, which reflects the presence 
of publication bias in the studies, was assessed using 
Begg’s and Egger’s tests. Begg and Mazumdar’s rank 
correlation tests the rank correlation (Kendall’s tau) 
between the standardized effect size and the variances 
(or standard errors) of these effects[14]; the Egger’s linear 
Caruso S et al . Robotic vs  open gastrectomy for cancer: Meta-analysis
276 June 10, 2017|Volume 8|Issue 3|WJCO|www.wjgnet.com
regression method[20] quantify the bias captured by the 
funnel plot. P value < 0.05 were considered to indicate 
statistical significance.
RESULTS
Study selection
The literature search yielded a total of 384 articles 
(Figure 1). After elimination of duplicates (n = 165), 
the remaining 219 titles and abstracts were reviewed. 
Based on the methodological inclusion and exclusion 
criteria, 196 studies were excluded: 115 did not compare 
techniques, 21 were non English studies, 60 were review 
articles, letters, case reports or comment. The full text 
of the remaining 23 articles were reviewed; of these, 
1 was excluded because it was a redundant and lower 
level series, 11 contained non relevant topics, 5 because 
it was impossible to retrieve or calculate data of interest. 
Finally, a total of 6 articles[21-26] (South Korea 2, China 2, 
Italy 1, Romania 1) were considered eligible for inclusion 
in the meta-analysis (Figure 1). 
Only one of these studies was a randomized controlled 
trial[26], while the others were retrospective non-ran-
domized trials. The same two authors extracted the 
number and characteristics of patients of both the RAG 
and OG groups, which globally included 6.123 patients. 
Huang et al[23] did not provide in their original papers 
data regarding means and standard deviations of peri-
operative outcome, which instead were expressed as 
medians and ranges. This additional initially unpublished 
information was retrieved from a previous meta-an-
alysis[27], in which the data was obtained by contacting the 
authors. 
The baseline characteristic, quality assessment and 
main perioperative data of the included studies were 
listed in Tables 1 and 2. 
Operative time
All included studies[21-26] reported a significantly longer 
operation time of the RAG group than OG (Table 2). The 
meta-analysis of pooled data (Figure 2A) confirmed the 
result showing a significantly lower operative time in the 
group of OG compared to RAG group (WMD: 72.20 min, 
95%CI: 48.82 to 105.13 min, P < 0.001). There was 
significant heterogeneity (I2 = 85%) (Figure 2A).
Estimated blood loss
All the included studies reported the mean intra-operative 
related to surgery estimated blood loss. A concordant 
result of statistical significantly lower blood loss volume 
in the RAG group than in the OG group (Table 2) was 
reported. The pool meta-analyzed data confirmed that 
blood loss was notably less in the RAG group as opposed 
to OG (WMD: -166.83 mL, 95%CI: -205.18 to -65.80 
mL, P < 0.001) with a significant heterogeneity between 
studies (I2 = 82%) (Figure 2B).
Harvested lymph nodes
The mean number of harvested lymph nodes was 
reported in all studies (Table 2). The pooled data from 
the included studies showed that the two groups did not 
differ significantly in the number of harvested lymph 
nodes (WMD = -1.12; 95%CI: -2.31 to 0.58; P = 0.10), 
with low heterogeneity between studies (I2 = 25%) 
(Figure 2C). 
Postoperative hospital stay: All the 6 included 
studies reported the length of hospital stay, showing in 
agreement a statistically significant reduction in favour 
of the RAG group compared to OG (Table 2). The meta-
analysis of combined data confirmed the result, showing 
shorter postoperative hospital stay in the RAG group 
Abstracts identified thorough database 
searching (n  = 384) and other sources 
(cross checking of reference lists, n  = 0)
Titles and Abstracts screened (n  = 219)
Full text articles screened for 
eligibility (n  = 23)
Duplicated articles removed (n  = 165)
Articles excluded based on inclusion and 
exclusion criteria (non English language, 
non comparative studies, non peri-
operative outcome): n  = 196
Full text excluded (redundant 
publication, non relevant topics, not 
sufficient data): n  = 17
Studies included (n  = 6)
Figure 1  Flow chart of study selection.
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compared to OG (Figure 2D). The robotic approach 
reduced the postoperative stay by a mean of 1.97 d (WMD 
= -1.97; 95%CI: -2.47 to -1.18 d; P < 0.001). Although 
there was a significant heterogeneity among the studies 
(I2 = 55%) (Figure 2D). 
Postoperative complications: Short-term posto-
perative complications were recorded in all analyzed 
studies. The meta-analysis did not significantly differ in 
the overall postoperative complication rate of the two 
groups (OR = 0.95, 95%CI: 0.60-1.34, P = 0.65) with 
low heterogeneity (I2=12%) (Figure 3A).
Five out of 6 studies[22-26] reported the incidence by 
group of the following subtype of early postoperative 
complications: wound infection, bleeding and anastomotic 
leakage. The meta-analysis of pooled data regarding 
these complications showed no difference between the 
two groups (respectively: Wound infection, OR = 1.48, 
95%CI: 0.86-3.12, P = 0.35, I2 = 10%; bleeding, OR = 
1.10, 95%CI: 0.40-4.49, P = 0.65, I2 = 0%; anastomotic 
leakage OR = 1.74, 95%CI: 0.99-3.05, P = 0.06, I2 = 0%) 
(Figure 3B-D).
Three studies out of 6[22-24] reported postoperative 
mortality rate value ranging from 0.5% to 3.3%, without 
statistically significant differences between the robotic and 
open procedures, while the rest of the studies[21,25,26] did 
not detect any case of mortality related to both surgical 
techniques (Table 2). A meta-analysis of pooled data was 
therefore considered unnecessary, as 50% of studies 
did not report any event of mortality in both groups and 
the data are insufficient to calculate an objective OR, 
thus the combined data reflected the evident equality of 
mortality rates among RAG and OG groups. 
Publication bias
A standard-error based funnel plot using fix effect size 
between RAG and OG was constructed for morbidity 
(Figure 4). The overall postoperative complication rate 
of all the studies lay within the limits of 95%CIs with 
just a slight asymmetry, indicating no serious publication 
Table 1  Baseline characteristics of include studies and quality assessment
Ref. Year Country Type of study Total 
patients (n )
Group n Sex (M/F) P 
value
Age (mean 
± SD)
P 
value
BMI (mean 
± SD)
P value Quality 
assessment
Kim et 
al[21]
2010 South 
Korea
Retrospective 
clinical trial
    28 RAG     16 10/6 NS   53.8 ± 15.6  
  56.0 ± 12.4
NS 21.3 ± 3.4 
25.2 ± 1.9
> 0.05 6 stars1
OG     12  9/3
Caruso et 
al[22]
2011 Italy Retrospective 
clinical trial
  149 RAG      29  18/11 NS    64.8 ± 12.4 
65.1 ± 11
NS 27 ± 3
28 ± 4
NS 6 stars1
OG   120  65/55
Huang et 
al[23]
2012 China Retrospective 
clinical trial
  625 RAG     39  19/20 < 0.05   65.1 ± 15.9 
  67.9 ± 30.1
NS 24.2 ± 3.7 
23.7 ± 3.6
NS 5 stars1
OG   586  406/180
Kim et 
al[24]
2012 South 
Korea
Retrospective 
clinical trial
4978 RAG   436  265/171 NS   54.2 ± 12.5 
  57.7 ± 11.8
< 0.05 23.6 ± 3.1 
23.8 ± 8.0
NS 5 stars1
OG 4542  3008/1534
Procopiuc 
et al[25]
2015 Romania Retrospective 
clinical trial
    47 RAG     18    13/5 NS   59.1 ± 13.7 
  60.1 ± 12.4
NS   26.0 ± 3.24 
  24.8 ± 4.58
NS 6 Stars1
OG     29    21/8
Wang et 
al[26]
2016 China Randomized 
clinical trial
  296 RAG   151 109/42 NS   57.5 ± 12.7 
  55.9 ± 13.1
NS 22.1 ± 2.9 
21.3 ± 2.5
NS 3 points2
OG   145   89/56
1According to the NOS (Newcastle-Ottawa Scale) classification; 2According to Jadad’s scale for reporting randomized controlled trials. RAG: Robot-assisted 
gastrectomy; OG: Open gastrectomy; NS: Not statistically significant.
Table 2  Main perioperative data of the included studies
Ref. Open 
conversion 
(%)
Group Operation 
time (min ± 
SD)1
P 
value
Blood loss 
(mL ± SD)1
P value Harvested 
nodes (n  ± 
SD)1 
P 
value
Morbidity 
(%)
P 
value
Mortality 
(%)
P 
value
Hospital stay 
(d ± SD)1 
P 
value
Kim et 
al[21]
0 RAG
OG
259.2 ± 38.9
126.7 ± 24.1
< 0.05   30.3 ± 15.1
  78.8 ± 74.1
< 0.05   41.1 ± 10.9
  43.3 ± 10.4
NS 0
20
NS 0
0
NS   5.1 ± 0.3
  6.7 ± 1.4
< 0.05
Caruso et 
al[22]
0 RAG 
OG
290 ± 67
222 ± 94
< 0.05   197.6 ± 202.1
386.1 ± 95.5
< 0.05   28.0 ± 11.2
  31.7 ± 15.6
NS 10.32
10.02
NS 0
3.3
NS   9.6 ± 2.8
13.4 ± 8.5
< 0.05
Huang et 
al[23]
NR RAG
OG
  415.9 ± 101.2
331.8 ± 92.9
< 0.05 93.9 ± 89
  192 ± 193
< 0.05      32 ± 13.7
    34 ± 14.8
NS 15.4
14.7
NS 1.4
2.6
NS   11.3 ± 14.4
  16.5 ± 13.6
< 0.05
Kim et 
al[24]
NR RAG
OG
226 ± 54
158 ± 52
< 0.05     85 ± 160
  192 ± 193
< 0.05   40.2 ± 15.5
  40.5 ± 16.6
NS 10.1
10.7
NS 0.5
0.5
NS 7.5
10.2
< 0.05
Procopiuc 
et al[25]
0 RAG
OG
320.8 ± 85.1
243.3 ± 57.9
< 0.05   208.2 ± 139.8
  564.6 ± 468.4
< 0.05 22.0 ± 8.9 
25.2 ± 9.0
NS 11.12
20.72
NS 0
0
NS   8.1 ± 2.0
11.4 ± 2.9
< 0.05
Wang et 
al[26]
1.93 RAG
OG
242.7 ± 43.8
192.4 ± 31.5
< 0.05   94.2 ± 51.5
152.8 ± 94.2
< 0.05 29.1 ± 6.7 
30.1 ± 7.2
NS 9.3
10.3
NS 0
0
NS   5.7 ± 2.3
  6.4 ± 2.5
< 0.05
1Mean value; 2Major complications rate base on Clavien-Dindo classification ≥ 3, such as anastomotic and duodenal lekeage; 3Rate of patients excluded 
from the study analysis. RAG: Robot-assisted gastrectomy; OG: Open gastrectomy; NS: Not statistically significant difference.
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biases. No evidence of publication bias was revealed 
among the studies from statistical tests for any primary 
outcomes (Begg’s test all P > 0.10; Egger’s test all P > 
0.10). 
A Operation time
RAG OG Mean difference Mean difference
Study or subgroup Mean SD Total Mean SD Total Weight IV, Random, 95%CI IV, Random, 95%CI
Kim MC 2010 259.2   38.9   16 126.7 24.1     12   16.3% 132.50 [109.06, 155.94]
Caruso S 2011 290.0   67.0   29 222.0 94.0   120   15.5%   68.00 [38.8, 97.62]
Huang KH 2012 415.9 101.2   39 331.8 92.9   586   14.5%   84.10 [51.46, 116.74]
Kim KM 2012 226.0   54.0 436 158.0 52.0 4542   19.6%   68.00 [62.71, 73.29]
Procopiuc L 2015 320.8   85.1   18 243.3 57.9     29   11.5%   77.47 [32.81, 122.12]
Wang G 2016 242.7   43.8 151 192.4 31.5   145   21.6%   50.30 [41.64, 58.96]
Total (95%CI) 689 5434 100.0%   72.20 [48.82, 105.13]
Heterogeneity: Tau2 = 1340.42; χ 2 = 58.09, 3 d.f., P  < 0.001; I 2 = 85%
Test for overall effect: Z  = 5.63, P  < 0.001
B Blood loss
RAG OG Mean difference Mean difference
Study or subgroup Mean SD Total Mean SD Total Weight IV, Random, 95%CI IV, Random, 95%CI
Kim MC 2010   30.3   15.1   16   78.8   74.1     12   18.3%   -48.50 [-91.7, -5.93]
Caruso S 2011 197.6 202.1   29 386.1   95.5   120   15.4% -188.50 [-264.04, -112.99]
Huang KH 2012   93.9   89.0   39 534.2 577.6   586   14.1% -440.30 [-494.77, -385.83]
Kim KM 2012   85.0 160.0 436 192.0 193.0 4542   19.6% -107.00 [-123.03, -90.97]
Procopiuc L 2015 208.2 139.8   18 564.6 468.4     29   12.1% -356.40 [-538.69, -174.04]
Wang G 2016   94.2   51.5 151 152.8   94.2   145   21.5%   -58.60 [-75.99, -41.21]
Total (95%CI) 689 5434 100.0% -166.83 [-205.18, -65.80]
Heterogeneity: Tau2 = 3468.72; χ 2 = 27.35, 3 d.f., P  < 0.001; I 2 = 82%
Test for overall effect: Z  = 4.53, P  < 0.001
C Harvested lymph nodes
RAG OG Mean difference Mean difference
Study or subgroup Mean SD Total Mean SD Total Weight IV, Random, 95%CI IV, Random, 95%CI
Kim MC 2010 41.1 10.9   16 43.3 10.4     12     1.1% -2.20 [-10.15, 5.75]
Caruso S 2011 28.0 11.1   29 31.7 15.6   120     5.8% -3.70 [-8.64, 1.24]
Huang KH 2012 32.0 13.7   39 34.0 14.8   586     6.2% -2.00 [-6.46, 2.46]
Kim KM 2012 40.2 15.5 436 40.5 16.6 4542   75.3% -0.30 [-1.83, 1.23]
Procopiuc L 2015 22.0   8.9   18 25.2   9.0     29     2.1% -3.20 [-8.46, 2.10]
Wang G 2016 29.1   6.7 151 30.1   7.2   145     9.5% -1.00 [-2.28, 0.28]
Total (95%CI) 689 5434 100.0% -1.12 [-2.31, 0.58]
Heterogeneity: χ 2 = 2.35, 3 d.f., P  = 0.20; I 2 = 25%
Test for overall effect: Z  = 1.42, P  = 0.10
D Postoperative hospital stay
RAG OG Mean difference Mean difference
Study or subgroup Mean SD Total Mean SD Total Weight IV, Random, 95%CI IV, Random, 95%CI
Kim MC 2010   5.1   0.3   16   6.7   1.4     12   27.5% -1.60 [-2.41, -0.79]
Caruso S 2011   9.6   2.8   29 13.4   8.5   120   12.6% -3.80 [-5.63, -1.97]
Huang KH 2012 11.3 14.4   39 16.5 13.6   586     5.6% -5.20 [-9.85, -0.55]
Kim KM 2012   7.5 13.7 436 10.2   8.5 4542   22.3% -2.70 [-4.01, -1.39]
Procopiuc L 2015   8.1   2.0   18 11.4   2.9     29   11.4% -3.30 [-4.36, -1.52]
Wang G 2016   5.7   2.3 151   6.4   2.5   145   20.6% -0.80 [-1.79, 0.19]
Total (95%CI) 689 5434 100.0% -1.97 [-2.47, -1.18]
Heterogeneity: Tau2 = 1.40; χ 2 = 8.18, 3 d.f., P  = 0.03; I 2 = 55%
Test for overall effect: Z  = 5.42, P  < 0.001
-200      -100         0        100       200
Favours RAG         Favours OG
-1000     -500          0        500       1000
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-10         -5           0          5         10
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-10         -5           0          5         10
Favours RAG         Favours OG
Figure 2  Forest plot showing the meta-analysis of pooled data on robot-assisted gastrectomy vs open gastrectomy. A: Operation time; B: Estimated blood 
loss; C: Harvested lymph nodes; D: Postoperative hospital stay. RAG: Robot-assisted gastrectomy; OG: Open gastrectomy.
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A Overall postoperative complication rate
RAG OG Odds ratio Odds ratio
Study or subgroup Events Total Events Total Weight M-H, fixed, 95%CI M-H, fixed, 95%CI
Kim MC 2010   0   16     2     12     4.1% 0.13 [0.01, 2.92]
Caruso S 2011 12   29   51   120     9.1% 0.96 [0.42, 2.17]
Huang KH 2012   6   39   86   586     7.5% 1.06 [0.43, 2.60]
Kim KM 2012 44 436 487 4542    60.5% 0.93 [0.67, 1.29]
Procopiuc L 2015 11   18     9     29     7.8% 3.49 [1.02, 11.97]
Wang G 2016 15 151   14   145   11.0% 0.97 [0.45, 2.08]
Total (95%CI) 689 5434 100.0% 0.95 [0.60, 1.34]
Total events 88 649
Heterogeneity: χ 2 = 2.58, 3 d.f., P  = 0.72; I 2 = 12%
Test for overall effect: Z  = 0.44, P  = 0.65
B Wound infection
RAG OG Odds ratio Odds ratio
Study or subgroup Events Total Events Total Weight M-H, fixed, 95%CI M-H, fixed, 95%CI
Caruso S 2011   1   29     4   120   14.2% 1.04 [0.11, 9.63]
Huang KH 2012   1   39   14   586   15.4% 1.08 [0.14, 8.40]
Kim KM 2012 14 436   93 4542   39.6% 1.59 [0.90, 2.81]
Procopiuc L 2015   2   18     1     29   10.1% 0.28 [0.02, 3.40]
Wang G 2016   3 151     4   145   20.7% 1.29 [0.28, 5.85]
Total (95%CI) 673 5422 100.0% 1.48 [0.86, 3.12]
Total events 21 116
Heterogeneity: χ 2 = 2.70, 2 d.f., P  = 0.52; I 2 = 10%
Test for overall effect: Z  = 0.88, P  = 0.35
C Bleeding
RAG OG Odds ratio Odds ratio
Study or subgroup Events Total Events Total Weight M-H, fixed, 95%CI M-H, fixed, 95%CI
Caruso S 2011 1   29   5   120   22.3% 0.82 [0.09, 7.31]
Huang KH 2012 0   39   3   586     7.4% 2.11 [0.11, 41.57]
Kim KM 2012 2 436 16 4542   32.8% 1.30 [0.30, 5.69]
Procopiuc L 2015 1   18   0     29   10.3% 5.06 [0.20, 131.05]
Wang G 2016 1 151   1   145   27.2% 1.29 [0.28, 5.85]
Total (95%CI) 673 5422 100.0% 1.10 [0.40, 4.49]
Total events 5 25
Heterogeneity: χ 2 = 0.73, 2 d.f., P  = 0.86; I 2 = 0%
Test for overall effect: Z  = 0.35, P  = 0.65
D Anastomotic leakage
RAG OG Odds ratio Odds ratio
Study or subgroup Events Total Events Total Weight M-H, fixed, 95%CI M-H, fixed, 95%CI
Caruso S 2011   1   29   7   120   13.3% 0.58 [0.07, 4.88]
Huang KH 2012   3   39 27   586   15.4% 1.73 [0.50, 5.96]
Kim KM 2012 10 436 51 4542   46.5% 2.07 [1.04, 4.10]
Procopiuc L 2015   2   18   1     29     6.3% 3.50 [0.29, 41.70]
Wang G 2016   4 151   3    145   18.5% 0.71 [0.16, 3.25]
Total (95%CI) 673 5422 100.0% 1.74 [0.99, 3.05]
20 89
Heterogeneity: χ 2 = 1.58, 2 d.f., P  = 0.68; I 2 = 0%
Test for overall effect: Z  = 1.95, P  = 0.06
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Sensitivity analysis: Sensitivity analysis was performed 
by excluding the study with the lowest quality score and 
the smallest sample size[21]. All variables were conducted 
for sensitivity analysis. The results were not affected by 
sensitivity analysis as shown in Table 3. 
DISCUSSION
Procedures which offer minimum invasiveness would 
present a perfectly acceptable alternative to open 
surgery, with better short-term results, if it were possible 
to respect oncologic criteria to the same degree as the 
open approach, and if there were no compromising 
effect on long-term survival. Even though long-term 
survival is one of the major oncologically prominent 
issue, lymph node metastasis has long been seen as 
the element which most significantly predicts recurrence 
and therefore survival in patients suffering from gastric 
0.01         0.1            1            10         100
Favours RAG         Favours OG
0.01        0.1             1           10           100
Favours RAG         Favours OG
0.01      0.1          1         10         100
Favours RAG         Favours OG
Figure 3  Forest plot showing the meta-analysis of postoperative complication between robot-assisted gastrectomy and open gastrectomy. A: Overall 
postoperative complications; B: Wound infection; C: Bleeding; D: Anastomotic leakage. RAG: Robot-assisted gastrectomy; OG: Open gastrectomy.
0.01      0.1          1         10         100
Favours RAG         Favours OG
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cancer[28]. Thus, the amount of harvested lymph nodes 
is an accurate reflection of whether gastric resection for 
adenocarcinoma is an adequate option, and can be used 
as indicator of oncological adequacy when no long follow-
up times are available. 
Total and distal gastrectomy with D2 lymphadene-
ctomy node is the recommended surgical procedure for 
most resectable gastric cancer patients[29]. LG with lymph 
node dissection has developed as a minimally invasive 
surgery for gastric cancer over the last two decades and it 
has been utilized principally for early gastric cancer. Some 
randomized studies and meta-analysis showed that LG 
with limited lymph node dissection for patients with early-
stage gastric lesion provided oncologic results which were 
not inferior compared to OG, with however improved 
short-term outcomes[2-5].
In contrast, a handful of trials, which all contained not 
large cohort of patients, outline the safety of laparoscopic 
assisted distal and total gastrectomy with D2 lymph node 
dissection in advanced-stage of gastric cancer. Several 
meta-analysis regarding this issue have been recently 
published. However, the outcomes were contradictory, 
especially regarding postoperative complications and the 
amount of harvested lymph nodes[30-32]. 
Thus, although LADG has been widely developed 
for early gastric cancer, the global effectiveness in 
therapeutic terms of LG still has not been extensively 
looked into with regards to the treatment of advanced-
stage of gastric cancer. Although a totally LG with 
extended D2 lymphadenectomy has been demonstrated 
to be feasible by several authors[33-36], owing to the 
intrinsic difficulty of execution, oncologic concerns 
still exist regarding the possibility of performing a D2 
lymphadenectomy radically and suitably. Indeed, the 
meta-analysis of the randomized controlled trials (RCTs) 
demonstrates that whenever results on LADG is gathered 
from advanced gastric cancers together with the early 
stage the same extent of lymph node dissection as in 
traditional surgery could not be guaranteed[37,38].
Although laparoscopic sub-D2 lymphadenectomy 
may be seen as suitable for nearly all early gastric cancer 
in which lymph node metastases rarely occur (2%-20% 
of cases)[37], and so far is routine in Asia[39], the same 
cannot be said about advanced gastric cancer and so LG 
cannot be advised as a standard approach for all patients 
with gastric cancer. 
With the development of technology, the introduction 
of a robotic tool as a useful adjunctive method to 
assist laparoscopy has gradually increased the use of 
minimally invasive procedures in several fields of surgery. 
For the treatment of gastric cancer, RAG has been 
widely demonstrated to be feasible and safe in many 
studies[8,40-49]. Robotic surgery is progressively becoming 
an attractive option for surgeons, in particular because it 
may overcome some intrinsic limitations of conventional 
laparoscopy, in particular for the D2 lymphadenectomy, 
expanding the application of minimally invasive pro-
cedures. In fact, this technique has certain indisputable 
advantages, such as high definition 3D imaging, improved 
dexterity enabled by the endowristed movements, tremors 
filtration, motion scaling, stereoscopic visualization, which 
are particular useful when precise dissection is needed, 
such as during the lymphadenectomy along major 
abdominal vessels (gastric, gastroepiploic, common 
hepatic, and celiac artery lymph nodes). Thus, as long as 
drawbacks of the LG technique exist, the introduction of 
new innovative technologies, such as robotic gastrectomy, 
are desirable. In fact, the median number of retrieved 
nodes, reported by many authors through the use of 
robotic system for D2 lymphadenectomy, is not dissimilar 
to that of traditional open technique, and in several 
instances even superior to laparoscopy[27,40,41,50-57].
However, significant limitations exist in the inter-
Table 3  Sensitivity analysis of outcomes
Outcomes No. of studies Patients WMD/OR Analysis 
model
95%CI P value Heterogeneity
RAG OG I 2 (%) P value
Operative time (min) 5[22-26] 673 5422    60.12 Random    41.31, 98.06 < 0.00001 80 0.41
Estimated blood loss (mL) 5[22-26] 673 5422 -193.78 Random -215.77, -72.13 < 0.0001 72   0.007
Harvested lymph nodes 5[22-26] 673 5422     -1.05 Random -2.01, 0.39 0.35   0 0.12
Overall postoperative complication 5[22-26] 673 5422      0.92 Fixed   0.61, 1.36 0.6 12 0.72
Postoperative hospital stay 5[22-26] 673 5422    -2.57 135.8 ± 133.9 -2.68, -1.56 < 0.001   0 0.54
RAG: Robot-assisted gastrectomy; OG: Open gastrectomy; WMD: Weighted mean difference; OR: Odds ratio.
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Figure 4  Funnel plot for results from each study comparing overall 
morbidity between robot-assisted gastrectomy and open gastrectomy. OR: 
Odds ratio; SE: Standard error.
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pretation of data available so far regarding the comparison 
of RAG with respect to OG, as a result of the shortage of 
randomized trials, the restricted amount of observational 
and comparative studies of high quality, the small 
sample sizes so far, and the shortened length of follow-
up. Therefore, there has been difficulty in drawing final 
conclusions regarding the superiority of one approach over 
another. 
A meta-analysis is a suitable way to widen the 
source of evidence. Evaluating pooled data among the 
most relevant studies is a quantitative method that 
may increase the statistical power of otherwise poorly 
consistent results and may resolve some controversy of 
evidence.
Robotic surgery is a technical innovation which 
improves the effectiveness of laparoscopic technique, 
which is used through the same laparoscopic way as a 
non independent adjunctive tool. Thus, we strictly limit 
the research by focusing exclusively on RAG with the 
intent to evaluate the real merit of the addition of robotic 
assistance to laparoscopy over the traditional OG for 
gastric cancer, performing a comprehensive systematic 
review and meta-analysis. Such a way of conducting 
the trial will provide a more objective appraisal of the 
effectiveness of RAG in gastric cancer patients, in order 
to confirm the single-institute promising results in 
favour of this innovative technique to date reported. This 
could represent the preliminary cue in support of the 
increasingly widespread view which considers robotics to 
be a completion of laparoscopy, making it possible to fill 
the existing performance gap with respect to OG. 
Six studies, of which 5 retrospective clinical trials and 
1 RCT, involving 6123 patients with 689 (11.3%) cases of 
RAG and 5434 (88.7%) of OG, were considered eligible 
for inclusion in this meta-analysis.
The results show globally that RAG provided short-
term results which can be compared to OG, with outcomes 
which can be considered as satisfactory with regards to 
perioperative results and oncological effectiveness. 
The operation time was significantly longer with 
RAG than OG (P < 0.001). The greater length of robotic 
surgery is principally due to the additional time for set-
up and docking of the robotic system[58]. Nevertheless, 
it should be noted that the time of operation notably 
diminished as surgical experience increased and the 
robotic procedure was standardized[8,47,59].
An advantageous lower blood loss and shorter 
hospital stay were revealed in favor of RAG, that can be 
principally due to globally lesser surgical damage than 
OG. The robotic system enables a meticulous and precise 
dissection in a magnified vision, which minimizes the 
risk of bleeding. Moreover, the technical advancement of 
the robotic device, which is provided by a high definition 
3D stereoscopic vision, enabling a better detection of 
vascular structures and allowing to easier inspect the 
bleeding occurring intra abdominally with tremor filtration 
and stable haemostatic strain provided with the robotic 
instrument. 
No statistical difference was observed between RAG 
and OG in terms of postoperative complication rate (P 
= 0.65), and also specifically referring to subcategories 
of complications, such as wound infection, bleeding, 
anastomotic leakage. In particular regarding the most 
feared adverse event after gastric cancer, the rate of 
anastomotic leakage is comparable to that reported by 
previous studies[60,61], ranging from 1% to 10%, and the 
rate among pooled data was 2.97% (20/673) for RAG 
and 1.64% (89/5422) for OG (P = 0.06).
Analysis of the pooled data revealed that the number 
of harvested lymph nodes was similar between RAG 
and OG. The feeling is that the technically advantageous 
properties of robotic surgery can easily and safely 
execute an effective, and oncologically adequate lym-
phadenectomy[62,63]. In particular, the meticulous 
dissection, together with the high 3D definition image 
and dexterity provided by the robotic system, seems to 
make the lymph node dissection safely feasible in difficult 
lymphatic stations around major vessels or in difficult 
area[6], with less blood loss[6,38]. 
The main limitation of this meta-analysis is that it 
does not resolve certain heterogeneity of the included 
studies, such as in terms of baseline characteristics of 
patients, type of gastrectomy, stage of disease, details of 
surgery, difference in reporting perioperative outcomes. 
For example, in the study of Kim et al[21] the body mass 
index (BMI) of the RAG group was significantly lower than 
that of the open (P = 0.0004). Huang et al[23] included 
patients in the robotic group which were associated with 
female predominance and were reconstructed mainly 
by Roux-en-Y anastomosis. In the study of Kim et al[24], 
the patients of RAG group were significantly younger 
than OG. Kim et al[24] and Huang et al[23] reported in their 
series a significantly higher proportion (P < 0.001) of 
advanced gastric cancers in the OG gastrectomy group 
with respect to the RAG group, that would suggest a 
corresponding higher number of lymph nodes retrieved 
in advanced stages than in early stages. Effectively, 
that reflects a trend of a higher amount of lymph nodes 
dissected with the open procedure than with the robotic 
technique, both in the single institute reports and in the 
pooling data meta-analysis, however this difference did 
not reach a statistical significance. Globally, this result 
suggests that RAG, even if applied in a greater proportion 
of early gastric cancer than OG, guarantees an adequate 
removal of lymph nodes, similar to that of OG in a larger 
amount of advanced gastric cancer. Since it was difficult 
to match baseline characters in all selected studies, the 
meta-analytic method planned the use of a random 
effected model to evaluate these parameters. However, 
high heterogeneity still existed in terms of operation 
time, blood loss and postoperative hospital stay, which 
the meta-analysis cannot completely resolve. 
However, the meta-analytic method can represent 
a valid preliminary analysis of the global framework 
of these data, eventually susceptible to a sub-set 
analysis of more homogeneous groups. Two previous 
meta-analysis[27,57], comparing RAG with conventional 
laparoscopy and OG, conducted a subgroup analysis 
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matched for some of these parameters, such as the 
extent of lymphadenectomy, type of gastrectomy 
(total or subtotal), and blood loss. However, the final 
results were substantially equal to the pooled data here 
presented in our meta-analysis. Moreover, although 
sensitivity analysis using matched data should reduce 
some of these potential bias, it cannot eliminate all of 
them and essentially it was impossible to match patient 
characteristics in all studies. For example, robotic 
procedures included the initial learning period, which may 
have resulted in an unequal surgical quality comparison. 
Moreover, most of the studies had small sample sizes 
with fewer than 50 RAG procedures and one single high-
volume centre (Kim et al[24]) contributed more than half 
of the total number of RAG; this uneven distribution in 
the number of patients contributed to heterogeneity. 
An advantage of our meta-analysis with respect to 
previous ones is that it included, even if only one, RCT 
and presently it is the most up to date work with the 
largest sample size comparing RAG and OG. 
In conclusion, RAG seems to offer a viable option to OG 
in treating gastric cancer patients. It allows the reduction 
of the estimated blood loss and the length of postoperative 
stay with respect to OG with, at the same time, a 
comparable oncologically adequate lymphadenectomy. 
The longer operative time did not seem to affect the 
patient’s recovery, with equal postoperative complications 
rate, risk of bleeding, wound infection and anastomotic 
leakage compared to open procedure.
Moreover, by overcoming some of the intrinsic 
limits of conventional laparoscopy, robotic gastrectomy 
probably represents the most promising technological 
innovation able to fill the gap still existing between 
laparoscopy and traditional open approach, particularly in 
the performance of D2 lymphadenectomy. 
That could make LG when assisted with the robotic tool 
more oncologically adequate and then more widespread, 
so as to maintain and expand the well-known advantages 
of a minimally invasive surgery with respect to the open 
procedure.
Future research should be directed towards comparing 
RAG to OG, to delineating significantly quantifiable advan-
tages between the two techniques, also in terms of cost 
analysis, especially in well-designed prospective randomized 
controlled trials. Finally, as a result of a lacking adequate 
follow-up and a small amount of high quality studies, it is 
too soon to formulate certain conclusive opinions.
COMMENTS
Background
Robot-assisted gastrectomy (RAG) is an innovative technique which improves 
the effectiveness of traditional laparoscopy, making it possible to overcome 
some of its typical limits. Several reports have demonstrated that this new 
procedure is technically feasible and safe, but no consensus is available in 
literature yet about the potential benefit of this technique with respect to the 
traditional open procedure. 
Research frontiers
Minimally invasive surgery has progressively improved and spread, because it 
offers a number of patient benefits compared to open surgery. Future research 
will be directed towards innovative techniques which could further minimize the 
surgical invasiveness for patients, so as to improve postoperative outcomes. 
From this point of view, RAG appears to be a promising advancement of 
minimally invasive surgery, and will probably continue to be increasingly used in 
the treatment of gastric cancer. 
Innovations and breakthroughs
Here the authors presented the meta-analysis of pooled data originating from 
the systematic review of relevant studies which compared short-term outcomes 
between RAG and open gastrectomy. Presently, this is the most up to date and 
largest clinical work comparing the effectiveness of these two techniques, and 
the only one that included a randomized controlled trial. 
Applications
The present work elucidates the current scientific evidence concerning the 
hypothesized beneficial application of RAG in gastric cancer patients. 
Peer-review
This paper is a meta-analysis of 6 reports comparing the outcomes of robot-
assisted laparoscopic gastrectomy for early gastric cancer with open gastrectomy, 
with favourable results for the former group. The information is important and 
needs to be made known. It is well written.
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